International standards and reference materials for quantitative molecular infectious disease testing

Journal of Molecular Diagnostics

Volumn 12, Issue 2, 2010, Pages 133-143

  Madej, Roberta M ^a   Davis, Jack ^b   Holden, Marcia J ^c   Kwang, Stan ^b   Labourier, Emmanuel ^d   Schneider, George J ^e  

^a Roche Molecular Diagnostics   (United States)

^b BIO RAD LABORATORIES   (United States)

^c NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^d ASURAGEN INC   (United States)

^e Abbott Molecular Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

CLINICAL LABORATORY; GOOD LABORATORY PRACTICE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION; LABORATORY DIAGNOSIS; MALARIA; PARVOVIRUS; PARVOVIRUS INFECTION; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; QUANTITATIVE DIAGNOSIS; REVIEW; STANDARD; WORLD HEALTH ORGANIZATION;

EID: 77649109592     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2010.090067     Document Type: Review

References (45)

1. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126:946-954
2. + counts predict both response to antiretroviral therapy and therapeutic failure: VA cooperative study group on AIDS. Ann Intern Med 1997, 126:983-985
3. Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working Party. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. J Gastroenterol Hepatol 2007, 22:615-633
4. Hammer SM, Saag MS, Schechter M, Montaner J, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CCJ, Fischel MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA: Treatment for adult HIV infection. 2006 recommendations of the AIDS society - USA panel. JAMA 2006, 296:827-843
5. Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL: A treatment algorithm for the management of chronic Hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006, 4:936-962
6. Best SJ, Gust AP, Johnson EIM, McGavin CH, Dax E: Quality of human immunodeficiency virus viral load testing in Australia. J Clin Microbiol 2000, 38:4015-4020
7. Schirm J, van Loon AM, Valetnine-Thon E, Klapper P, Reid J, Cleator G: External quality assessment program for qualitative and quantitative detection of hepatitis C virus RNA in diagnostic virology. J Clin Microbiol 2002, 40:2973-2980
8. Zaaijer HL, Cuypers HT, Reesink HW, Winkel IN, Gerken G, Lelie PN: Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993, 341:722-724
9. Clinical and Laboratory Standards Institute: Quantitative Molecular Methods for Infectious Diseases; Approved Guideline. CLSI Document MM6-A. Wayne, PA, Clinical and Laboratory Standards Institute, 2003, p 30
10. World Health Organization: Annex Ii Recommendations for the Preparation, Characterization and Establishment of International and Other Biological Reference Standards (revised 2004). WHO Technical Report Series, No. 932. Geneva, World Health Organization, 2006, p 80
11. Saldanha J, Heath A, Lelie N, WHO Collaborative Study Group: Establishment of the first international standard for nucleic acid amplification technology assays for HCV RNA. Vox Sang 1999, 76:149-158
12. Saldanha J, Heath A, Aberham C, Albrecht J, Gentili G, Gessner M, Pisani G: World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays. Vox Sang 2005, 88:202-204
13. Baylis SA, Heath AB, Collaborative Study Group: WHO collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays, BS07.2055. Geneva, World Health Organization, 2007
14. Saldanha J, Heath A, Lelie N, Collaborative Study Group: Collaborative study to calibrate hepatitis C virus genotypes 2-6 against the HCV international standard 96/790 (genotype 1). Vox Sang 2003, 84:20-27
15. Saldanha J, Heath A, Lelie N, Pisani G, Nubling M, Yu R, Collaborative Study Group: Calibration of HCV working reagents for NAT assays against the HCV international standard. Vox Sang 2000, 78:217-224
16. Saldanha J: Standardization: a progress report. Biologicals 1999, 27:285-289
17. Saldanha J: Validation and standardization of nucleic acid amplification technology (NAT) assays for the detection of viral contamination of blood and blood products. J Clin Virol 2001, 20:7-13
18. Holmes H, Davis C, Heath A, Hewlett I, Lelie N: An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001, 92:141-150
19. Saldanha J, Gerlach W, Lelie N, Dawson P, Heerman K, Health A, WHO Collaborative Study Group: An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001, 80:63-71
20. Saldanha J, Heath A, Lelie N, Pisani G, Yu MY, Collaborative Study Group: A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays. Vox Sang 2005, 89:52-58
21. Saldanha J, Lelie N, Yu MW, B19 Collaborative Study Group: Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques. Vox Sang 2002, 82:24-31
22. Wilkinson DE, Heath AB, Ferguson M, World Health Organization Human Papillomavirus DNA International Collaborative Study Group: WHO collaborative study to establish WHO international standards for human papillomavirus type 16 DNA and type 18 DNA nucleic acid amplification technology (NAT)-based assays. Int J Cancer, 2009 [Epub PMID: 19904756]
23. Padley D, Heath A, Sutherland A, Chiodini PL, Baylis S, Collaborative Study Group: Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays. Malar J 2008, 7:139-147
24. World Health Organization: Development of WHO biological reference preparations for blood safety related in vitro diagnostic tests: report of a meeting with the WHO Collaborating Centres for Biological Standards and Standardization. Geneva, World Health Organization, 2007
25. Hendricks DA: Ideal design characteristics of international standards for quantification of viruses. WHO Consultation on International Standards for in Vitro Clinical Diagnostics Procedures Based on Nucleic Acid Techniques (NAT). Geneva, World Health Organization, 2002, 4-5
26. Halfon P, Bourliere M, Penaranda G, Khiri H, Ouzan D: Real-time PCR assays for hepatitis C virus (HCV) RNA quantification are adequate for clinical management of patients with chronic HCV infection. J Clin Microbiol 2006, 44:2507-2511
27. Muller Z, Stelzl E, Bozic M, Haas J, March E, Kessler HH: Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA. J Clin Microbiol 2004, 42:1439-1443
28. Preiksaitis JK, Pang XL, Fox JD, Fenton JM, Caliendo AM, Miller GG: Interlaboratory comparison of Epstein-Barr virus viral load assays. Am J Transplant 2009, 9:269-279
29. Hayden RT, Hokanson KM, Pounds SB, Bankowski MJ, Belzer SW, Carr J, Diorio D, Forman MS, Joshi Y, Hillyard D, Hodinka RL, Nikiforova MN, Romain CA, Stevenson J, Valsamakis A, Balfour HH Jr: Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus. J Clin Microbiol 2008, 46:157-163
30. Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK: Interlaboratory Comparison of Cytomegalovirus Viral Load Assays. Am J Transplant 2009, 9:258-268
31. Collins ML, Zayati C, Detmer J, Daly B, Kolberg JA, Cha T-A, Irving BD, Tucker J, Urdea MS: Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995, 226:120-129
32. Caliendo AM, St. George K, Kao S-Y, Allega J, Tan B-H, LaFontaine R, Bui L, Rinaldo CR: Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype Amplicor CMV monitor test in transplant recipients. J Clin Microbiol 2000, 3:2122-2127
33. Nye MB, Leman AR, Meyer ME, Menegus MA, Rothberg PG: Sequence diversity in the glycoprotein B gene complicates real-time PCR assays for detection and quantification of cytomegalovirus. J Clin Microbiol 2005, 43:4968-4971
34. Lengerova M, Racil Z, Volfova P, Lochmanova J, Berkovcova J, Dvorakava D, Vorlicek J, Mayer J: Real-time PCR diagnostics failure caused by nucleotide variability within exon 4 of the human cytomegalovirus major immediate-early gene. J Clin Microbiol 2007, 45:1042-1044
35. Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA, Yao JDC, Wengenack NL, Rosenblatt JE, Cockerill FR, Smith TF: Realtime PCR in clinical microbiology: applications for a routine laboratory testing. Clin Microbiol Rev 2006, 19:165-200
36. Marchini A, Liu H, Zhu H: Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J. Virol 2001, 75:1870-1878
37. Wang W, Patterson CE, Yang S, Zhu H: Coupling generation of cytomegalovirus deletion mutants and amplification of viral BAC clones. J Virol Methods 2004, 121:137-143
38. Stinski MF, Mocarski ES, Thomsen DR: DNA of human cytomegalovirus size heterogeneity and defectiveness resulting from serial undiluted passage. J Virol 1979, 31:231-239
39. Holden MJ, Rabb SA, Tewari YB, Winchester MR: Traceable phosphorus measurements by ICP-OES and HPLC for the quantification of DNA. Anal Chem 2007, 79:1536-1541
40. International Standards Organization: In vitro diagnostic medical devices - measurement of quantities in samples of biological origin. Presentation of reference measurement procedures. ISO Document 15193. Geneva, International Standards Organization, 2002, 9-16
41. International Standards Organization: In vitro diagnostic medical devices - ;Measurement of quantities in samples of biological origin. Description of reference materials. ISO Document 15194. Geneva, International Standards Organization, 2002
42. Armbruster D, Miller RR: The Joint Committee for Traceability in Laboratory Medicine (JCTLM): a global approach to promote the standardization of clinical laboratory test results. Clin Biochem Rev 2007, 28:105-113
43. Miller WG, Myers GL, Rej R: Why commutability matters. Clin Chem 2006, 52:553-554
44. Vesper HW, Miller WG, Myers GL: Reference materials and commutability. Clin Biochem Rev 2007, 28:139-147
45. Clinical and Laboratory Standards Institute: Characterization and quantification of commutable reference materials for laboratory medicine, proposed guideline. CLSI Document C53-P. Wayne, PA, Clinical and Laboratory Standards Institute, 2008